Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing surveillance of AKUUGO intracerebral transplantation for chronic motor paralysis after traumatic brain injury
jRCT2033250850Not yet recruiting
- Sponsor
- SanBio
- Start
- Mar 2026
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of apitegromab, sponsored by SanBio. Primary endpoint: Effectiveness and safety in routine clinical practice. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
apitegromab
Beyond the preview
Go deeper on jRCT2033250850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2033250850.